Solara Active Pharma Sciences Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 11:09 am
06-11-2025 | 11:09 am
Solara Pharma's board approved the financial results for the quarter and half-year. For Q2, consolidated loss was Rs. 10.10 Cr on Rs. 313.54 Cr revenue. The company plans to raise Rs. 134.99 Cr via its rights issue and is exploring demerging its CRAMS & Polymers business.
No comments yet. Be the first to comment!
All announcements from Solara Active Pharma Sciences Limited
